NCT00466674View on ClinicalTrials.gov

Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Myeloma

Interventions

DRUG

reduced intensity conditioning

reduced intensity conditioning for allogenic transplant

Trial Locations (1)

69437

Mohamad Sobh, Lyon

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT00466674 - Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning | Biotech Hunter | Biotech Hunter